ClinicalTrials.Veeva

Menu

Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients

S

Sohag University

Status

Unknown

Conditions

Macular Edema

Study type

Observational

Funder types

Other

Identifiers

NCT05209971
Soh-Med-22-01-05

Details and patient eligibility

About

In this study, measurements of central macular thickness using optical coherence tomography along with examination of visual acuity by Snellen's chart in diabetic hypertensive patients will be done .

Full description

correlate relationship between optical coherence tomography changes and visual acuity in patients with type 2 diabetes and hypertension

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Type 2 diabetic patients with hypertension .

Exclusion criteria

  • Patients with type 1 diabetes mellitus .
  • Ocular disease ( such as high myopia , glaucoma ) .
  • Patients with opacities in the media ( corneal opacities , dense cataract , vitreous hemorrhage ) .
  • Systemic medication (Tamoxifen , Chloroquine , Canthaxanthine ) to avoid its effect on macular thickness .
  • Central visual field defect that prevents fixation on OCT .
  • Intraocular inflammation such as anterior or posterior uveitis .
  • Refractive error greater than 6 diopter .

Trial design

100 participants in 1 patient group

macular thickness and visual acuity
Description:
optical coherence tomography

Trial contacts and locations

0

Loading...

Central trial contact

Alahmady Hamad, professor; Gamal Abdelateef, professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems